數位乳房斷層合成設備市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品類型、最終用戶地區和競爭細分，2019-2029F

2023 年，全球數位乳房斷層合成設備市場估值為30.2 億美元，預計在預測期內將強勁成長，到2029 年複合年成長率為9.89%。 ，以創新、技術為特徵。乳房斷層合成，也稱為 3D 乳房 X 光檢查，與傳統 2D 乳房 X 光檢查相比，透過提供更好的乳房組織可視化，徹底改變了乳房影像。在乳癌發病率增加、人們對早期檢測重要性的認知不斷提高以及影像技術進步等因素的推動下，該市場出現了顯著成長。隨著世界各地的醫療保健系統優先考慮預防保健和個人化治療方法，數位乳房斷層合成已成為對抗乳癌的重要工具。該市場涵蓋各種設備，包括數位乳房斷層合成系統、影像處理和分析軟體解決方案以及相關配件。該市場的主要參與者不斷投資於研發，以增強其產品的功能，並專注於提高影像解析度、更快的掃描時間和提高工作流程效率等功能。

市場概況
預測期	2025-2029
2023 年市場規模	30.2億美元
2029 年市場規模	53億美元
2024-2029 年複合年成長率	9. 89%
成長最快的細分市場	2D/3D 組合乳房 X 光攝影系統
最大的市場	北美洲

技術進步在塑造數位乳房斷層合成設備市場方面發揮關鍵作用，3D 引導活體組織切片系統、人工智慧 (AI) 驅動的影像分析軟體和改進的人體工學設計等創新提高了診斷準確性和患者舒適度。這些進步不僅有助於乳癌的早期發現，而且使醫療保健提供者能夠提供更個人化和精確的治療策略。此外，數位乳房斷層合成與超音波和磁振造影 (MRI) 等其他影像方式的整合正在促進乳癌診斷的多模式方法，從而實現全面評估和更好的患者治療結果。

主要市場促進因素

乳癌發生率上升

越來越重視早期檢測和篩檢計劃

成像技術的技術進步

主要市場挑戰

初始設定成本高

報銷問題

監管障礙

主要市場趨勢

3D 乳房 X 光攝影的採用率不斷提高

與多模態成像方法整合

細分市場洞察

產品類型見解

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球數位乳房斷層合成設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品類型（2D/3D 組合乳房 X 光檢查系統、獨立 3D 乳房 X 光檢查系統）
  • 按最終使用者（醫院、診斷中心、其他最終使用者）
  • 按地區
  • 按公司分類 (2023)
• 市場地圖
  • 依產品類型
  • 按最終用戶
  • 按地區

第 6 章：亞太地區數位乳房斷層合成設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品類型
  • 按最終用戶
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 澳洲
  • 日本
  • 韓國

第 7 章：歐洲數位乳房斷層合成設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品類型
  • 按最終用戶
  • 按國家/地區
• 歐洲：國家分析
  • 法國
  • 德國
  • 西班牙
  • 義大利
  • 英國

第 8 章：北美數位乳房斷層合成設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品類型
  • 按最終用戶
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第 9 章：南美洲數位乳房斷層合成設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品類型
  • 按最終用戶
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東及非洲數位乳房斷層合成設備市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品類型
  • 按最終用戶
  • 按國家/地區
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 埃及

第 11 章：市場動態

• 促進要素
• 挑戰

第 12 章：市場趨勢與發展

• 最近的發展
• 產品發布
• 併購

第 13 章：全球數位乳房斷層合成設備市場：SWOT 分析

第 14 章：波特的五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第15章：競爭格局

• PerkinElmer Inc. (Dexela Ltd.)
• Hologic, Inc
• GE HealthCare Technologies Inc.
• Fujifilm Holdings Corporation
• Siemens Healthineers
• General Medical Merate SpA (IMS GIOTTO SPA)
• Varex Imaging Corporation
• Trivitron Healthcare
• Metaltronica Spa
• Analogic Corporation

第 16 章：策略建議

第17章調查會社について,免責事項

Global Digital Breast Tomosynthesis Equipment Market was valued at USD 3.02 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 9.89% through 2029. The Global Digital Breast Tomosynthesis Equipment Market is a dynamic landscape characterized by innovation, technological advancements, and a growing emphasis on early detection and precise diagnosis of breast cancer. Breast tomosynthesis, also known as 3D mammography, has revolutionized breast imaging by offering improved visualization of breast tissue compared to traditional 2D mammography. This market has witnessed significant growth driven by factors such as increasing incidences of breast cancer, rising awareness about the importance of early detection, and advancements in imaging technology. As healthcare systems worldwide prioritize preventive care and personalized treatment approaches, digital breast tomosynthesis has emerged as a crucial tool in the arsenal against breast cancer. The market encompasses a wide range of equipment, including digital breast tomosynthesis systems, software solutions for image processing and analysis, and associated accessories. Key players in this market are continuously investing in research and development to enhance the capabilities of their products, focusing on features like improved image resolution, faster scan times, and enhanced workflow efficiency.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 3.02 Billion
Market Size 2029	USD 5.30 Billion
CAGR 2024-2029	9. 89%
Fastest Growing Segment	2D/3D Combination Mammography Systems
Largest Market	North America

Technological advancements play a pivotal role in shaping the digital breast tomosynthesis equipment market, with innovations such as 3D-guided biopsy systems, artificial intelligence (AI)-powered image analysis software and improved ergonomic designs enhancing diagnostic accuracy and patient comfort. These advancements not only facilitate early detection of breast cancer but also enable healthcare providers to offer more personalized and precise treatment strategies. Furthermore, the integration of digital breast tomosynthesis with other imaging modalities such as ultrasound and magnetic resonance imaging (MRI) is fostering a multimodal approach to breast cancer diagnosis, allowing for comprehensive evaluation and better patient outcomes.

Key Market Drivers

Rising Incidence of Breast Cancer

The rising incidence of breast cancer is a significant driver behind the growth of the global digital breast tomosynthesis equipment market. Breast cancer remains one of the most common types of cancer among women worldwide, with millions of new cases diagnosed each year. Factors such as aging populations, lifestyle changes, and increased awareness leading to more screenings contribute to the rising incidence rates.

As the number of breast cancer cases continues to climb, there is a growing emphasis on early detection as a crucial factor in improving survival rates and treatment outcomes. Digital breast tomosynthesis (DBT) offers several advantages over traditional 2D mammography, including improved sensitivity and specificity in detecting breast abnormalities. The ability of DBT to provide three-dimensional images of breast tissue helps radiologists identify lesions more accurately, reducing false-positive and false-negative results.

Healthcare providers are increasingly turning to DBT equipment to enhance their breast cancer screening and diagnostic capabilities. By adopting DBT technology, healthcare facilities can offer their patients a more advanced and comprehensive screening experience, leading to earlier detection of breast cancer and potentially better patient outcomes. Regulatory bodies and healthcare organizations are recognizing the clinical benefits of DBT and incorporating it into breast cancer screening guidelines and recommendations. This growing acceptance and endorsement of DBT as a preferred imaging modality for breast cancer detection further drive its adoption in healthcare settings worldwide.

The rising incidence of breast cancer also underscores the need for continuous innovation and improvement in breast imaging technology. Manufacturers are investing in research and development to enhance the performance and capabilities of digital breast tomosynthesis equipment, focusing on areas such as image resolution, workflow efficiency, and patient comfort. These advancements not only improve the diagnostic accuracy of DBT but also make it more accessible and user-friendly for healthcare providers and patients alike.

Growing Emphasis on Early Detection and Screening Programs

The growing emphasis on early detection and screening programs is a key driver propelling the expansion of the global digital breast tomosynthesis equipment market. Early detection plays a critical role in improving treatment outcomes and survival rates for breast cancer patients, making it a primary focus for healthcare systems worldwide. Screening programs aim to identify breast abnormalities at their earliest stages, when treatment options are most effective, and chances of survival are highest.

Digital breast tomosynthesis (DBT) has emerged as a powerful tool in breast cancer screening due to its ability to provide three-dimensional images of breast tissue with enhanced clarity and detail compared to traditional 2D mammography. The superior sensitivity and specificity of DBT in detecting breast abnormalities contribute to its increasing adoption in screening programs globally. Healthcare organizations, advocacy groups, and governmental agencies are actively promoting breast cancer screening initiatives to raise awareness and encourage early detection among women. These programs often incorporate digital breast tomosynthesis technology as part of their screening protocols, offering patients access to advanced imaging modalities that improve the accuracy and reliability of breast cancer detection.

The integration of DBT into organized screening programs and routine clinical practice has become more widespread as healthcare providers recognize the clinical benefits of this technology. Digital breast tomosynthesis enables radiologists to detect smaller lesions, identify architectural distortions, and reduce false-positive and false-negative findings, leading to more accurate diagnoses and better patient outcomes. In addition to traditional screening programs, there is a growing trend towards personalized screening approaches that take into account individual risk factors and preferences. Digital breast tomosynthesis equipment allows for tailored screening protocols based on a patient's breast density, family history, genetic predisposition, and other relevant factors, optimizing the effectiveness of screening efforts and minimizing unnecessary interventions.

Technological Advancements in Imaging Technology

Technological advancements in imaging technology are playing a pivotal role in driving the growth of the global digital breast tomosynthesis equipment market. As the field of medical imaging continues to evolve, manufacturers are constantly innovating to enhance the capabilities and performance of digital breast tomosynthesis (DBT) equipment, leading to improved diagnostic accuracy and patient outcomes. One of the key technological advancements driving the adoption of digital breast tomosynthesis equipment is the development of higher-resolution imaging sensors and detectors. These advancements enable DBT systems to capture detailed three-dimensional images of breast tissue with greater clarity and precision, enhancing the ability of radiologists to detect subtle abnormalities and lesions.

Advancements in image reconstruction algorithms and processing software have significantly improved the quality of DBT images while reducing noise and artifacts. Sophisticated reconstruction techniques such as iterative reconstruction and model-based algorithms enhance image resolution and contrast, enabling more accurate interpretation of breast images and reducing the likelihood of false-positive and false-negative findings. Another important technological advancement in DBT equipment is the integration of artificial intelligence (AI) and machine learning algorithms. AI-powered image analysis software can automatically detect and highlight suspicious areas on breast images, assisting radiologists in their interpretation and decision-making process. These AI algorithms can also analyze large datasets of breast images to identify patterns and trends, potentially leading to the development of more precise diagnostic tools and predictive models for breast cancer detection.

Also, advancements in ergonomic design and user interface enhancements have made digital breast tomosynthesis equipment more user-friendly and efficient for healthcare providers. Streamlined workflows, intuitive software interfaces, and ergonomic features such as adjustable compression paddles improve the overall user experience and workflow efficiency, enabling radiologists to perform more screenings in less time.

Key Market Challenges

High Initial Setup Costs

One of the primary challenges hindering the adoption of digital breast tomosynthesis equipment is the high initial setup costs associated with acquiring and implementing this technology. Healthcare facilities, particularly in resource-constrained settings, may face budgetary constraints that limit their ability to invest in expensive imaging equipment. The cost of purchasing DBT systems, along with installation, training, and maintenance expenses, can pose a significant financial burden on healthcare providers, impeding the widespread adoption of digital breast tomosynthesis technology.

Reimbursement Issues

Reimbursement policies and coverage for digital breast tomosynthesis procedures vary across different regions and healthcare systems, leading to inconsistencies and uncertainties regarding reimbursement for screening and diagnostic services. In some cases, reimbursement rates may not adequately cover the costs associated with DBT procedures, limiting healthcare providers' incentive to invest in this technology. Additionally, delays or denials in reimbursement approvals can create financial challenges for healthcare facilities, discouraging them from adopting digital breast tomosynthesis equipment.

Regulatory Hurdles

Regulatory approval processes for medical devices, including digital breast tomosynthesis equipment, can be lengthy, complex, and costly. Manufacturers must adhere to stringent regulatory requirements and standards set forth by regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to ensure the safety, efficacy, and quality of their products. Delays in obtaining regulatory approvals or compliance with evolving regulatory requirements can significantly impact product launch timelines and market access, posing challenges for manufacturers seeking to introduce new digital breast tomosynthesis technologies.

Key Market Trends

Increasing Adoption of 3D Mammography

The increasing adoption of 3D mammography is a pivotal factor driving the growth of the global digital breast tomosynthesis (DBT) equipment market. 3D mammography, also known as digital breast tomosynthesis (DBT), has emerged as a preferred imaging modality for breast cancer screening and diagnosis due to its superior capabilities compared to traditional 2D mammography.

3D mammography provides a three-dimensional view of the breast tissue, allowing radiologists to examine breast images layer by layer, thereby improving the detection of breast abnormalities, including small tumors and lesions. This enhanced sensitivity and specificity of 3D mammography in detecting breast cancer have led to its widespread adoption among healthcare providers worldwide. The adoption of 3D mammography is driving the demand for digital breast tomosynthesis equipment, as DBT systems are specifically designed to perform 3D mammography imaging. Healthcare facilities are investing in DBT equipment to upgrade their breast imaging capabilities and offer patients access to advanced screening technologies.

Moreover, the clinical benefits of 3D mammography, including improved cancer detection rates and reduced false-positive findings, are driving market growth. Studies have demonstrated that 3D mammography detects more cancers compared to 2D mammography alone while also decreasing the number of false-positive results, leading to more accurate diagnoses and reducing unnecessary follow-up procedures. Regulatory bodies and healthcare organizations are endorsing the use of 3D mammography in breast cancer screening programs, further fueling its adoption. Guidelines from organizations such as the American Cancer Society and the European Society of Breast Imaging recommend the use of DBT as part of routine breast cancer screening for certain patient populations.

Integration with Multimodal Imaging Approaches

The integration of digital breast tomosynthesis (DBT) with multimodal imaging approaches is emerging as a key driver of growth in the global digital breast tomosynthesis equipment market. Multimodal imaging combines the strengths of different imaging modalities, such as ultrasound, magnetic resonance imaging (MRI), and DBT, to provide a more comprehensive evaluation of breast lesions and improve diagnostic accuracy.

By integrating DBT with other imaging modalities, healthcare providers can obtain complementary information about breast tissue morphology, composition, and vascularity, enhancing the diagnostic capabilities of DBT equipment. This integrated approach enables radiologists to better characterize breast lesions, differentiate between benign and malignant lesions, and guide treatment planning.

One of the primary benefits of integrating DBT with multimodal imaging approaches is the ability to overcome the limitations of individual imaging modalities. While DBT excels in detecting architectural distortions and microcalcifications associated with breast cancer, it may have limitations in visualizing certain types of lesions, such as cysts or masses with complex morphologies. By combining DBT with ultrasound or MRI, healthcare providers can obtain additional information about lesion morphology, vascularity, and tissue composition, enhancing diagnostic confidence and reducing the need for additional imaging studies. Multimodal imaging approaches enable more personalized and precise treatment planning for breast cancer patients. By incorporating information from multiple imaging modalities, healthcare providers can tailor treatment strategies based on individual patient characteristics, such as tumor size, location, and histological features. This personalized approach improves treatment outcomes and reduces the risk of undertreatment or overtreatment, leading to better patient care and satisfaction.

The integration of DBT with multimodal imaging approaches also streamlines the diagnostic workflow and improves efficiency in breast imaging centers. Rather than performing separate imaging studies using different modalities, healthcare providers can perform comprehensive evaluations using a single imaging session, saving time and resources for both patients and providers.

Segmental Insights

Product Type Insights

Based on the product type, therapeutics segment emerged as the dominant segment in the global digital breast tomosynthesis equipment market in 2023. This is primarily due to the combined benefits offered by both 2D and 3D mammography technologies, making it a preferred choice among healthcare providers and patients alike. 2D mammography has been the standard screening tool for breast cancer detection for many years, offering reliable results and widespread availability. However, it has limitations, particularly in detecting lesions in dense breast tissue and differentiating between overlapping structures. On the other hand, 3D mammography, or digital breast tomosynthesis (DBT), provides a three-dimensional view of the breast tissue, allowing for better visualization and characterization of breast lesions.

Regional Insights

North America solidified its position as the leading region in the global digital breast tomosynthesis equipment market, capturing the largest market share. This dominance can be attributed to North America's robust healthcare infrastructure, characterized by advanced medical facilities and well-established breast cancer screening programs. With a high level of healthcare expenditure, the region fosters a conducive environment for the adoption of innovative medical technologies, including digital breast tomosynthesis equipment.

Healthcare providers in North America increasingly integrate digital breast tomosynthesis into routine clinical practice, recognizing its effectiveness in detecting breast cancer and reducing false positives. The technology's ability to provide three-dimensional images of the breast improves diagnostic accuracy and enhances the early detection of abnormalities, contributing to better patient outcomes. North America's proactive approach to breast cancer awareness and screening initiatives further drives the adoption of digital breast tomosynthesis equipment. Government-led campaigns and advocacy efforts raise awareness about the importance of early detection, encouraging women to undergo regular screenings with advanced imaging technologies.

Key Market Players

PerkinElmer Inc. (Dexela Ltd.)

Hologic, Inc

GE HealthCare Technologies Inc.

Fujifilm Holdings Corporation

Siemens Healthineers

General Medical Merate SpA (IMS GIOTTO SPA)

Varex Imaging Corporation

Trivitron Healthcare

Metaltronica Spa

Analogic Corporation

Report Scope:

In this report, the Global Digital Breast Tomosynthesis Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

********Digital Breast Tomosynthesis Equipment Market, By Product Type:

Diagnostics Therapeutics

********Digital Breast Tomosynthesis Equipment Market, By End-User:

Hospitals Diagnostic Centers Other End-Users

Digital Breast Tomosynthesis Equipment Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Breast Tomosynthesis Equipment Market.

Available Customizations:

Global Digital Breast Tomosynthesis Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customers

5. Global Digital Breast Tomosynthesis Equipment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (2D/3D Combination Mammography Systems, Standalone 3D Mammography Systems)
  • 5.2.2. By End-User (Hospitals, Diagnostic Centers, Other End-Users)
  • 5.2.3. By Region
  • 5.2.4. By Company (2023)
• 5.3. Market Map
  • 5.3.1. By Product Type
  • 5.3.2. By End-User
  • 5.3.3. By Region

6. Asia Pacific Digital Breast Tomosynthesis Equipment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Digital Breast Tomosynthesis Equipment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By End-User
  • 6.3.2. India Digital Breast Tomosynthesis Equipment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By End-User
  • 6.3.3. Australia Digital Breast Tomosynthesis Equipment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By End-User
  • 6.3.4. Japan Digital Breast Tomosynthesis Equipment Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product Type
      • 6.3.4.2.2. By End-User
  • 6.3.5. South Korea Digital Breast Tomosynthesis Equipment Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product Type
      • 6.3.5.2.2. By End-User

7. Europe Digital Breast Tomosynthesis Equipment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By End-User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Digital Breast Tomosynthesis Equipment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By End-User
  • 7.3.2. Germany Digital Breast Tomosynthesis Equipment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By End-User
  • 7.3.3. Spain Digital Breast Tomosynthesis Equipment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By End-User
  • 7.3.4. Italy Digital Breast Tomosynthesis Equipment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By End-User
  • 7.3.5. United Kingdom Digital Breast Tomosynthesis Equipment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By End-User

8. North America Digital Breast Tomosynthesis Equipment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By End-User
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Digital Breast Tomosynthesis Equipment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By End-User
  • 8.3.2. Mexico Digital Breast Tomosynthesis Equipment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By End-User
  • 8.3.3. Canada Digital Breast Tomosynthesis Equipment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By End-User

9. South America Digital Breast Tomosynthesis Equipment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By End-User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Digital Breast Tomosynthesis Equipment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By End-User
  • 9.3.2. Argentina Digital Breast Tomosynthesis Equipment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By End-User
  • 9.3.3. Colombia Digital Breast Tomosynthesis Equipment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By End-User

10. Middle East and Africa Digital Breast Tomosynthesis Equipment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By End-User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Digital Breast Tomosynthesis Equipment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By End-User
  • 10.3.2. Saudi Arabia Digital Breast Tomosynthesis Equipment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By End-User
  • 10.3.3. UAE Digital Breast Tomosynthesis Equipment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By End-User
  • 10.3.4. Egypt Digital Breast Tomosynthesis Equipment Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Product Type
      • 10.3.4.2.2. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Digital Breast Tomosynthesis Equipment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. PerkinElmer Inc. (Dexela Ltd.)
  • 15.1.1. Company Snapshot
  • 15.1.2. Products & Services
  • 15.1.3. Financials (In case of listed)
  • 15.1.4. Recent Developments
  • 15.1.5. SWOT Analysis
• 15.2. Hologic, Inc
• 15.3. GE HealthCare Technologies Inc.
• 15.4. Fujifilm Holdings Corporation
• 15.5. Siemens Healthineers
• 15.6. General Medical Merate SpA (IMS GIOTTO SPA)
• 15.7. Varex Imaging Corporation
• 15.8. Trivitron Healthcare
• 15.9. Metaltronica Spa
• 15.10. Analogic Corporation

16. Strategic Recommendations

17. About Us & Disclaimer